Literature DB >> 6091834

Effects of raubasine stereoisomers on pre- and postsynaptic alpha-adrenoceptors in the rat vas deferens.

P Demichel, J Roquebert.   

Abstract

The actions of raubasine, tetrahydroalstonine and akuammigine were studied on pre- and postsynaptic alpha-adrenoceptors of the rat vas deferens. These three drugs competitively antagonized the effect of noradrenaline on postsynaptic alpha-adrenoceptors, yielding pA2 values of 6.57, 4.56 and 4.68 respectively. The presynaptic alpha-adrenoceptor antagonist activity of the drugs was quantitatively determined by studying the effect of increasing concentrations on the clonidine dose-response curve in the electrically stimulated vas deferens. The inhibitory effect of clonidine could be competitively blocked by these three compounds and the pA2 values for raubasine, tetrahydroalstonine and akuammigine were 6.02, 7.71 and 5.64 respectively. These results indicate that: akuammigine is a very weak antagonist at pre- and postsynaptic sites; raubasine acts preferentially at postsynaptic sites; tetrahydroalstonine is a highly selective presynaptic alpha-adrenoceptor blocking agent. The ratio of the pre/postsynaptic potency declines in the order tetrahydroalstonine greater than akuammigine greater than raubasine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091834      PMCID: PMC1987108          DOI: 10.1111/j.1476-5381.1984.tb16514.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.

Authors:  J M VAN ROSSUM
Journal:  Arch Int Pharmacodyn Ther       Date:  1963

2.  [Adrenolytic and sympatholytic effect of two new Rauwolfia alkaloids, Raupin and Raubasin, on blood pressure and on nictitating membrane of cat].

Authors:  G KRONEBERG; J D ACHELIS
Journal:  Arzneimittelforschung       Date:  1954-04

3.  Further sub-classification of alpha-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat [proceedings].

Authors:  J R Docherty; A MacDonald; J C McGrath
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

Review 4.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

5.  Comparison of the effects of clonidine on pre- and postsynaptic adrenoceptors in the rabbit pulmonary artery. Alpha-sympathomimetic inhibition of Neurogenic vasoconstriction.

Authors:  K Starke; H Montel; W Gayk; R Merker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Pre- and postsynaptic alpha-adrenoceptor blocking activity of raubasine in the rat vas deferens.

Authors:  P Demichel; P Gomond; J Roquebert
Journal:  Br J Pharmacol       Date:  1981-12       Impact factor: 8.739

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  [Pharmacology of the Rauwolfia alkaloid raubasin (gamma-yohimbine, ajmalicin)].

Authors:  G KRONEBERG
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

Review 9.  Evidence for more than one type of post-junctional alpha-adrenoceptor.

Authors:  J C McGrath
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

10.  Prazosin selectively inhibits the responses to field stimulation in the rat vas deferens.

Authors:  S A Doggrell
Journal:  Eur J Pharmacol       Date:  1981-05-22       Impact factor: 4.432

  10 in total
  4 in total

1.  Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism.

Authors:  O Pastoris; M Dossena; P Foppa; R Arnaboldi; A Gorini; R F Villa; G Benzi
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

2.  Synaptosomal non-mitochondrial ATPase activities and drug treatment.

Authors:  G Benzi; A Gorini; B Ghigini; R Arnaboldi; R F Villa
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

3.  Modifications by hypoxia and drug treatment of cerebral ATPase plasticity.

Authors:  G Benzi; A Gorini; B Ghigini; R Arnaboldi; R F Villa
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

4.  The alkaloid alstonine: a review of its pharmacological properties.

Authors:  E Elisabetsky; L Costa-Campos
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-16       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.